Glenmark Pharmaceuticals Limited(IN:GLENMARK)
₹2,648.00+27.00 (+1.03%)
IN:GLENMARK
Glenmark Pharmaceuticals Limited earnings date
₹2,648.00
At close:+27.00 (+1.03%)
Want to see IN:GLENMARK full AI Analyst Report?
Glenmark Pharmaceuticals Limited (GLENMARK) Q3 2022 Earnings Report
5 Followers
IN:GLENMARK Q3 2022 EPS Results
- Actual EPS
- INR 12.30
- Consensus EPS
- INR 965.32
- Beat/Miss
- Missed by -INR 953.02
- One Year Ago EPS
- INR 8.48
IN:GLENMARK Q3 2022 Revenue Results
- Actual Revenue
- INR 31.73B
- Expected Revenue
- INR 2.84T
- Beat/Miss
- Missed by -INR 2.81T
- YoY Revenue Growth
- +13.87%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 02/11/2022
- Time
- During Market Hours
- Conference Call
- Friday, February 11, 2022
IN:GLENMARK Upcoming Earnings
Glenmark Pharmaceuticals Limited's next earnings date is estimated for February 5, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IN:GLENMARK Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 05, 2027 | 2027 (Q3) | ―- | 14.28 | ― | ― |
| Nov 05, 2026 | 2027 (Q2) | 15.609.34 | 21.62 | -56.80% (-12.28) | |
| Jul 31, 2026 | 2027 (Q1) | 17.3017.11 | 1.66 | 930.72% (+15.45) | |
| May 29, 2026 | 2026 (Q4) | 18.2010.68 | 8.75 | 22.06% (+1.93) | |
| Jan 30, 2026 | 2026 (Q3) | 18.7014.28 | 12.3 | 16.10% (+1.98) | |
| Nov 14, 2025 | 2026 (Q2) | ―21.62 | 12.55 | 72.27% (+9.07) | |
| Aug 14, 2025 | 2026 (Q1) | 12.901.66 | 12.06 | -86.24% (-10.40) | |
| May 23, 2025 | 2025 (Q4) | 12.108.75 | -44.04 | 119.87% (+52.79) | |
| Feb 14, 2025 | 2025 (Q3) | 14.0512.30 | -12.5 | 198.40% (+24.80) | |
| Nov 14, 2024 | 2025 (Q2) | 14.7012.55 | 6.9 | 81.88% (+5.65) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

